U.S. Markets open in 33 mins.

Spherix Incorporated (SPEX)

NASDAQ Capital Market - NASDAQ Capital Market Delayed Price. Currency in USD
Add to watchlist
1.49-0.08 (-5.10%)
At close: 4:00PM EDT
People also watch
MBRXXGTIIDXGHMNYTOPS
Full screen
Previous Close1.57
Open1.51
Bid1.30 x 1500
Ask1.60 x 700
Day's Range1.24 - 1.55
52 Week Range0.83 - 4.75
Volume486,661
Avg. Volume1,597,530
Market Cap9.28M
Beta-1.40
PE Ratio (TTM)0.26
EPS (TTM)5.64
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date1980-05-12
1y Target Est19.00
Trade prices are not sourced from all markets
  • Spherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board
    PR Newswire8 days ago

    Spherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board

    NEW YORK, Aug. 15, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to the fostering of technology, today announced the addition of Dr. Scott T. Tagawa to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in evaluating potential opportunities in the biopharmaceutical arena. Dr. Scott T. Tagawa, MD, MS is the Richard A. Stratton Associate Professor in Hematology and Oncology and an Associate Professor of Clinical Medicine and of Clinical Urology at Weill Cornell Medicine.

  • Spherix Issues Letter to Shareholders
    PR Newswire21 days ago

    Spherix Issues Letter to Shareholders

    NEW YORK, Aug. 2, 2017 /PRNewswire/ -- Spherix Incorporated (SPEX) an intellectual property development company committed to fostering of technology, today issued a letter to shareholders. It is with great pleasure that I take this opportunity to update you on recent events at the Company and describe in greater detail our strategic path forward.   The fundamentals at Spherix are stronger than they have been in recent memory and our path to value creation is moving forward with precision and focus.

  • Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics Inc.
    PR Newswire27 days ago

    Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics Inc.

    NEW YORK, July 27, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to fostering of technology, today announced that Anthony Hayes, CEO of Spherix Inc., joins the board of directors at Hoth Therapeutics Inc.